全文获取类型
收费全文 | 1629篇 |
免费 | 121篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 71篇 |
妇产科学 | 33篇 |
基础医学 | 340篇 |
口腔科学 | 19篇 |
临床医学 | 202篇 |
内科学 | 366篇 |
皮肤病学 | 19篇 |
神经病学 | 167篇 |
特种医学 | 33篇 |
外科学 | 153篇 |
综合类 | 2篇 |
预防医学 | 127篇 |
眼科学 | 5篇 |
药学 | 90篇 |
中国医学 | 6篇 |
肿瘤学 | 113篇 |
出版年
2023年 | 14篇 |
2022年 | 8篇 |
2021年 | 25篇 |
2020年 | 20篇 |
2019年 | 20篇 |
2018年 | 40篇 |
2017年 | 29篇 |
2016年 | 43篇 |
2015年 | 49篇 |
2014年 | 63篇 |
2013年 | 68篇 |
2012年 | 137篇 |
2011年 | 174篇 |
2010年 | 55篇 |
2009年 | 45篇 |
2008年 | 137篇 |
2007年 | 126篇 |
2006年 | 110篇 |
2005年 | 136篇 |
2004年 | 127篇 |
2003年 | 122篇 |
2002年 | 122篇 |
2001年 | 11篇 |
2000年 | 5篇 |
1999年 | 7篇 |
1998年 | 3篇 |
1997年 | 6篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 6篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 4篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1975年 | 2篇 |
1969年 | 1篇 |
1932年 | 1篇 |
排序方式: 共有1752条查询结果,搜索用时 31 毫秒
21.
22.
Priyanka Patel Jasna Kriz Mathieu Gravel Geneviève Soucy Christine Bareil Claude Gravel Jean-Pierre Julien 《Molecular therapy》2014,22(3):498-510
There is emerging evidence that the misfolding of superoxide dismutase 1 (SOD1) may represent a common pathogenic event in both familial and sporadic amyotrophic lateral sclerosis (ALS). To reduce the burden of misfolded SOD1 species in the nervous system, we have tested a novel therapeutic approach based on adeno-associated virus (AAV)–mediated tonic expression of a DNA construct encoding a secretable single-chain fragment variable (scFv) antibody composed of the variable heavy and light chain regions of a monoclonal antibody (D3H5) binding specifically to misfolded SOD1. A single intrathecal injection of the AAV encoding the single-chain antibody in SOD1G93A mice at 45 days of age resulted in sustained expression of single-chain antibodies in the spinal cord, and it delayed disease onset and extension of life span by up to 28%, in direct correlation with scFv titers in the spinal cord. The treatment caused attenuation of neuronal stress signals and reduction in levels of misfolded SOD1 in the spinal cord of SOD1G93A mice. From these results, we propose that an immunotherapy based on intrathecal inoculation of AAV encoding a secretable scFv against misfolded SOD1 should be considered as potential treatment for ALS, especially for individuals carrying SOD1 mutations. 相似文献
23.
24.
25.
Paul R. Odgren Carole A. MacKay April Mason-Savas Meiheng Yang Geneviève Mailhot Mark J. Birnbaum 《Connective tissue research》2013,54(4):229-234
Escherichia coli β-galactosidase (β-gal), encoded by the lacZ gene, has become an essential tool in studies of gene expression and function in higher eukaryotes. lac-Z is widely used as a marker gene to detect expression of transgenes or Cre recombinase driven by tissue-specific promoters. The timing and location of promoter activity is easily visualized in whole embryos or specific tissues using the cleavable, chromogenic substrate, 5-bromo-4-chloro-3-indolyl-D-galactopyranoside (X-gal). The tissue specificity of promoters in transgenic constructs is routinely tested by using a promoter of choice to drive lacZ. Alternatively, the targeted expression of Cre recombinase to perform in vivo recombination of loxP sites can be visualized by β-gal staining in mice carrying a Cre-activated lacZ transgene, such as the ROSA26 strain. In the course of our investigations, we examined β-gal activity in bone tissue from genetically normal mice using standard detection methodology and found very high endogenous activity in bone-resorbing osteoclasts. This was true in frozen, paraffin, and glycol methacrylate sections. X-gal staining colocalized with the osteoclast marker, tartrate-resistant acid phosphatase (TRAP). β-gal activity was present in osteoclasts in long bones, in the mandible, and in both neonatal and more mature animals. We present this brief article as a caution to those testing genetic models of skeletal gene expression using β-gal as a marker gene. 相似文献
26.
Véronique Chajès Carine Biessy Graham Byrnes Geneviève Deharveng Mitra Saadatian-Elahi Mazda Jenab 《Nutrition and cancer》2013,65(8):1235-1250
Elaidic acid is the main unnatural trans fatty acid isomer occurring during partial hydrogenation of vegetable oils used as ingredients for the formulation of processed foods. The main objective is to assess associations between processed food intakes and plasma phospholipid elaidic acid concentrations within the European Prospective Investigation into Cancer and Nutrition study. A cross-sectional study was used to determine fatty acid profiles in 3,003 subjects from 16 centers. Single 24-h dietary recalls (24-HDR) were collected using a standardized computerized interview program. Food intakes were computed according to their degree of processing (moderately/nonprocessed foods, processed staple foods, highly processed foods). Adjusted ecological and individual correlations were calculated between processed food intakes and plasma elaidic acid levels. At the population level, mean intakes of highly processed foods were strongly correlated with mean levels of plasma elaidic acid in men (P = 0.0016) and in women (P = 0.0012). At the individual level, these associations remained but at a much lower level in men (r = 0.08, P = 0.006) and in women (r = 0.09, P = 0.0001). The use of an averaged 24-HDR measure of highly processed food intakes is adequate for predicting mean levels of plasma elaidic acid among European populations. 相似文献
27.
28.
29.
Geneviève Cadieux Vanessa Redditt Daniela Graziano Meb Rashid 《Journal of immigrant and minority health / Center for Minority Public Health》2017,19(1):6-14
Several outbreaks of varicella have occurred among refugees. We aimed to estimate the prevalence of varicella susceptibility among refugees, and identify risk factors for varicella susceptibility. All refugees rostered at Crossroads Clinic in Toronto, Canada in 2011–2014 were included in our study. Varicella serology was assessed at the initial visit. Refugees’ age, sex, education, time since arrival, and climate and population density of birth country were abstracted from the chart. Multivariate logistic regression was used to identify risk factors for varicella susceptibility. 1063 refugees were rostered at Crossroads Clinic during the study; 7.9 % (95 % CI 6.1, 9.7) were susceptible to varicella. Tropical climate (OR 3.20, 95 % CI 1.53, 6.69) and younger age (ORper year of age 0.92, 95 % CI 0.88–0.96) were associated with increased varicella susceptibility. These risk factors for varicella susceptibility should be taken into account to maximize the cost-effectiveness of varicella prevention strategies among refugees. 相似文献
30.
Mohamed-Aziz Barkaoui Emma Queheille Nathalie Aladjidi Geneviève Plat Eric Jeziorski Despina Moshous Anne Lambilliotte Kamila Kebaili Hélène Pacquement Guy Leverger Ludovic Mansuy Natacha Entz-Werlé Damien Bodet Pascale Schneider Anne Pagnier Anne Lutun Marion Gillibert-Yvert Fréderic Millot Fabienne Toutain Yves Reguerre Caroline Thomas Abdelatif Tazi Jean-François Emile Jean Donadieu Sébastien Héritier 《British journal of haematology》2020,191(5):825-834
The nucleoside analogue, 2-chlorodeoxyadenosine (2CDA), was reported to be an active treatment for childhood Langerhans cell histiocytosis (LCH) without risk organ (RO−) involvement. However, we lack data on long-term effects of 2CDA treatment, including the disease reactivation rate, permanent sequelae and long-term tolerance. This study included 44 children from the French LCH registry, treated for a RO− LCH with 2CDA monotherapy (median number of six courses). The median age at the beginning of 2CDA was 3·6 years (range, 0·3–19·7 years) and the median follow-up after was 5·4 years (range, 0·6–15·1 years). Objective response to 2CDA was observed in 25 patients (56·8%), while six patients (13·6%) had stable disease and 13 patients (29·5%) exhibited progressive disease. Among patients without progression, only two experienced disease reactivation after 2CDA discontinuation. The five-year cumulative incidence of disease progression or reactivation after 2CDA therapy initiation was 34·3%. The lymphopenia reported in all cases [72% below absolute lymphocyte count (ALC) of 0·5 G/l], was addressed with appropriate prophylactic measures. Other toxicities above grade 2 were uncommon, and no second malignant neoplasm or neuropathy was reported. The five-year overall survival was 97·7%. In conclusion, we could confirm that 2CDA monotherapy was a beneficial long-term therapy for treating patients with RO− LCH. Appropriate management of induced immune deficiency is mandatory. 相似文献